Central Nervous System

The products developed to affect the central nervous system are an important and constantly growing part of Richter’s product range. One focus area for our original drug research is the development of new central nervous system drugs.


One of Richter’s best known original products is used in the treatment of chronic cerebral circulatory disorders and has been on the market for more than thirty years.

In addition, our central nervous system drugs include anaesthetics, anti-anxiety medications, sleeping pills, modern anti-epileptic medicines as well as a product for treating neuropathic pain.

The strategic objective for Richter is to provide a continuously expanding product line in this segment too. We currently have several candidate molecules that one day will provide effective treatments for depression, schizophrenia and other bipolar disorders.